Aemetis (AMTX) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Aemetis (AMTX) over the last 13 years, with Q3 2025 value amounting to $59.2 million.
- Aemetis' Cost of Revenue fell 2361.31% to $59.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $211.9 million, marking a year-over-year decrease of 2671.27%. This contributed to the annual value of $268.2 million for FY2024, which is 4521.93% up from last year.
- As of Q3 2025, Aemetis' Cost of Revenue stood at $59.2 million, which was down 2361.31% from $55.6 million recorded in Q2 2025.
- Aemetis' 5-year Cost of Revenue high stood at $77.6 million for Q3 2024, and its period low was $3.4 million during Q1 2023.
- In the last 5 years, Aemetis' Cost of Revenue had a median value of $55.6 million in 2025 and averaged $56.9 million.
- As far as peak fluctuations go, Aemetis' Cost of Revenue plummeted by 9374.98% in 2023, and later soared by 202553.69% in 2024.
- Aemetis' Cost of Revenue (Quarter) stood at $51.7 million in 2021, then skyrocketed by 31.32% to $67.9 million in 2022, then grew by 3.0% to $69.9 million in 2023, then dropped by 29.84% to $49.0 million in 2024, then rose by 20.81% to $59.2 million in 2025.
- Its last three reported values are $59.2 million in Q3 2025, $55.6 million for Q2 2025, and $48.0 million during Q1 2025.